NCT03214588 - Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

December 27, 2018

Study Completion Date

December 27, 2018

Conditions

Friedreich Ataxia

Interventions

DRUG

TAK-831

TAK-831 tablets

DRUG

TAK-831 Placebo

TAK-831 placebo matching tablets

Trial Locations (6)

The Children's Hospital of Philadelphia, Philadelphia

University of Florida Center for Movement Disorders, Gainesville

USF College of Medicine, Tampa

Ohio State University Wexner Medical Center, Columbus

University of Iowa Children's Hospital, Iowa City

UCLA Ataxia Center, Los Angeles